?? Pioneering early-stage medical device trials in LatAm

James Sapirstein's extensive pharmaceutical career spans over three decades. As President and CEO of AzurRx BioPharma, he brings a wealth of experience to the industry.

Key Points:

• Leads AzurRx BioPharma as President and CEO
• Boasts 35+ years of pharmaceutical industry experience
• Contributed to nearly two dozen drug product launches
• Played key roles in multiple HIV therapeutic breakthroughs
• Holds a leadership position with a NASDAQ-listed company

Why It Matters: Sapirstein's extensive drug development and commercialization background drives innovation in the pharmaceutical sector, potentially leading to new treatments for patients worldwide.

Read more: https://subscribe.bioaccessla.com/archive/home/4124196-Your-Newsletter279440/1228639556